NSE
Tatva Chintan Pharma Chem LimitedTATVA
Tatva Chintan Pharma Chem Limited is an NSE-listed company (TATVA).
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Re 1 Per Share
ex 2025-09-12
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | TATVAThis | +₹0 Cr | 10 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — TATVA day by day
- 2026-06-12FilingTatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meetInvestor Call
- 2025-10-15BulkBUY · ₹16.2 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-10-15BulkSELL · ₹16.2 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-10-15BulkBUY · ₹18.1 CrMUSIGMA SECURITIES
- 2025-10-15BulkSELL · ₹18.1 CrMUSIGMA SECURITIES
- 2025-09-12ActionDividend - Re 1 Per ShareDividend
- 2025-07-25BulkSELL · ₹25 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-07-25BulkBUY · ₹25 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-07-25BulkBUY · ₹13.8 CrMUSIGMA SECURITIES
- 2025-07-25BulkSELL · ₹13.8 CrMUSIGMA SECURITIES
- 2025-07-18BulkBUY · ₹13.2 CrGRAVITON RESEARCH CAPITAL LLP
- 2025-07-18BulkSELL · ₹13.2 CrGRAVITON RESEARCH CAPITAL LLP
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2
10 deals · 2025-07-18 → 2025-10-15
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2025-10-15 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹16.2 Cr |
| 2025-10-15 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹16.2 Cr |
| 2025-10-15 | MUSIGMA SECURITIES | Prop / churn | BUY | ₹18.1 Cr |
| 2025-10-15 | MUSIGMA SECURITIES | Prop / churn | SELL | ₹18.1 Cr |
| 2025-07-25 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹25 Cr |
| 2025-07-25 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹25 Cr |
| 2025-07-25 | MUSIGMA SECURITIES | Prop / churn | BUY | ₹13.8 Cr |
| 2025-07-25 | MUSIGMA SECURITIES | Prop / churn | SELL | ₹13.8 Cr |
| 2025-07-18 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | BUY | ₹13.2 Cr |
| 2025-07-18 | GRAVITON RESEARCH CAPITAL LLP | Prop / churn | SELL | ₹13.2 Cr |
10 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on TATVA
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.